218 related articles for article (PubMed ID: 34149719)
1. Circulating and Tumor-Infiltrating NK Cells From Clear Cell Renal Cell Carcinoma Patients Exhibit a Predominantly Inhibitory Phenotype Characterized by Overexpression of CD85j, CD45, CD48 and PD-1.
Ziblat A; Iraolagoitia XLR; Nuñez SY; Torres NI; Secchiari F; Sierra JM; Spallanzani RG; Rovegno A; Secin FP; Fuertes MB; Domaica CI; Zwirner NW
Front Immunol; 2021; 12():681615. PubMed ID: 34149719
[TBL] [Abstract][Full Text] [Related]
2. CD16
Frazao A; Messaoudene M; Nunez N; Dulphy N; Roussin F; Sedlik C; Zitvogel L; Piaggio E; Toubert A; Caignard A
Cancer Immunol Res; 2019 Feb; 7(2):208-218. PubMed ID: 30514793
[TBL] [Abstract][Full Text] [Related]
3. The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology.
Secchiari F; Nuñez SY; Sierra JM; Ziblat A; Regge MV; Raffo Iraolagoitia XL; Rovegno A; Ameri C; Secin FP; Richards N; Ríos Pita H; Vitagliano G; Rico L; Mieggi M; Frascheri F; Bonanno N; Blas L; Trotta A; Friedrich AD; Fuertes MB; Domaica CI; Zwirner NW
Oncoimmunology; 2022; 11(1):2104991. PubMed ID: 35936986
[TBL] [Abstract][Full Text] [Related]
4. NK and T cells with a cytotoxic/migratory phenotype accumulate in peritumoral tissue of patients with clear cell renal carcinoma.
Strizova Z; Taborska P; Stakheev D; Partlová S; Havlova K; Vesely S; Bartunkova J; Smrz D
Urol Oncol; 2019 Jul; 37(7):503-509. PubMed ID: 31030972
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic markers and frequency predict functional capacity of natural killer cells infiltrating renal cell carcinoma.
Schleypen JS; Baur N; Kammerer R; Nelson PJ; Rohrmann K; Gröne EF; Hohenfellner M; Haferkamp A; Pohla H; Schendel DJ; Falk CS; Noessner E
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):718-25. PubMed ID: 16467081
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Experienced Human NK Cells Express High Levels of PD-L1 and Inhibit CD8
Sierra JM; Secchiari F; Nuñez SY; Iraolagoitia XLR; Ziblat A; Friedrich AD; Regge MV; Santilli MC; Torres NI; Gantov M; Trotta A; Ameri C; Vitagliano G; Pita HR; Rico L; Rovegno A; Richards N; Domaica CI; Zwirner NW; Fuertes MB
Front Immunol; 2021; 12():745939. PubMed ID: 34616407
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma.
Giraldo NA; Becht E; Vano Y; Petitprez F; Lacroix L; Validire P; Sanchez-Salas R; Ingels A; Oudard S; Moatti A; Buttard B; Bourass S; Germain C; Cathelineau X; Fridman WH; Sautès-Fridman C
Clin Cancer Res; 2017 Aug; 23(15):4416-4428. PubMed ID: 28213366
[No Abstract] [Full Text] [Related]
8. PD-1 expression on peripheral blood cells increases with stage in renal cell carcinoma patients and is rapidly reduced after surgical tumor resection.
MacFarlane AW; Jillab M; Plimack ER; Hudes GR; Uzzo RG; Litwin S; Dulaimi E; Al-Saleem T; Campbell KS
Cancer Immunol Res; 2014 Apr; 2(4):320-31. PubMed ID: 24764579
[TBL] [Abstract][Full Text] [Related]
9. Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging.
Eckl J; Buchner A; Prinz PU; Riesenberg R; Siegert SI; Kammerer R; Nelson PJ; Noessner E
J Mol Med (Berl); 2012 Jan; 90(1):55-66. PubMed ID: 21870102
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of activation markers in renal cell carcinoma infiltrating lymphocytes.
Shabtai M; Ye H; Frischer Z; Martin J; Waltzer WC; Malinowski K
J Urol; 2002 Nov; 168(5):2216-9. PubMed ID: 12394762
[TBL] [Abstract][Full Text] [Related]
11. Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma.
Viey E; Fromont G; Escudier B; Morel Y; Da Rocha S; Chouaib S; Caignard A
J Immunol; 2005 Feb; 174(3):1338-47. PubMed ID: 15661891
[TBL] [Abstract][Full Text] [Related]
12. A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma.
Gui CP; Wei JH; Chen YH; Fu LM; Tang YM; Cao JZ; Chen W; Luo JH
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34237133
[TBL] [Abstract][Full Text] [Related]
13. Natural immune reactivity-associated therapeutic response in patients with metastatic renal cell carcinoma receiving tumor-infiltrating lymphocytes and interleukin-2-based therapy.
Belldegrun A; Tso CL; Kaboo R; Pang S; Pierce W; deKernion JB; Figlin R
J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):149-61. PubMed ID: 8732698
[TBL] [Abstract][Full Text] [Related]
14. Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma.
Mou Y; Wu J; Zhang Y; Abdihamid O; Duan C; Li B
BMC Cancer; 2021 Jan; 21(1):18. PubMed ID: 33402128
[TBL] [Abstract][Full Text] [Related]
15. Immune classification of clear cell renal cell carcinoma.
Su S; Akbarinejad S; Shahriyari L
Sci Rep; 2021 Feb; 11(1):4338. PubMed ID: 33619294
[TBL] [Abstract][Full Text] [Related]
16. High Numbers of Circulating CD57
Muntasell A; Servitja S; Cabo M; Bermejo B; Pérez-Buira S; Rojo F; Costa-García M; Arpí O; Moraru M; Serrano L; Tusquets I; Martínez MT; Heredia G; Vera A; Martínez-García M; Soria L; Comerma L; Santana-Hernández S; Eroles P; Rovira A; Vilches C; Lluch A; Albanell J; López-Botet M
Cancer Immunol Res; 2019 Aug; 7(8):1280-1292. PubMed ID: 31189644
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome Analysis of Tumor-Infiltrating Lymphocytes Identifies NK Cell Gene Signatures Associated With Lymphocyte Infiltration and Survival in Soft Tissue Sarcomas.
Judge SJ; Bloomstein JD; Sholevar CJ; Darrow MA; Stoffel KM; Vick LV; Dunai C; Cruz SM; Razmara AM; Monjazeb AM; Rebhun RB; Murphy WJ; Canter RJ
Front Immunol; 2022; 13():893177. PubMed ID: 35874727
[TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes.
Schleypen JS; Von Geldern M; Weiss EH; Kotzias N; Rohrmann K; Schendel DJ; Falk CS; Pohla H
Int J Cancer; 2003 Oct; 106(6):905-12. PubMed ID: 12918068
[TBL] [Abstract][Full Text] [Related]
19. Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation.
Hood SP; Foulds GA; Imrie H; Reeder S; McArdle SEB; Khan M; Pockley AG
Front Immunol; 2018; 9():3169. PubMed ID: 30761160
[No Abstract] [Full Text] [Related]
20. Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.
Kawakami F; Sircar K; Rodriguez-Canales J; Fellman BM; Urbauer DL; Tamboli P; Tannir NM; Jonasch E; Wistuba II; Wood CG; Karam JA
Cancer; 2017 Dec; 123(24):4823-4831. PubMed ID: 28832979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
